menu
    • menu

    Company profile for Navidea Biopharmaceuticals

    NEW Drugs in Dev: 6
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Today in the face of illness, millions of people are confronted with diagnostic uncertainty. As patients and their physicians seek accurate diagnosis of their condition, precision diagnostics are playing important new roles in medicine, and are helping to inspire the growing presence of precision medicine today. Navidea Biopharmaceuticals (NYSEMKT: NAVB) is a global leader in precision diagnostics which pinpoint molecular sit...
    Today in the face of illness, millions of people are confronted with diagnostic uncertainty. As patients and their physicians seek accurate diagnosis of their condition, precision diagnostics are playing important new roles in medicine, and are helping to inspire the growing presence of precision medicine today. Navidea Biopharmaceuticals (NYSEMKT: NAVB) is a global leader in precision diagnostics which pinpoint molecular sites and pathways to identify the presence and status of disease. Through our innovative and flexible platforms and products, we are committed to improving diagnostic accuracy & empowering clinical decision-making.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Navidea BiopharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4995 Bradenton Avenue Suite 240 Dublin, OH 43017
    Telephone
    Telephone
    614-793-7500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.navidea.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Navidea Biopharmaceuticals Files For Chapter 11 Bankruptcy
    Navidea Biopharmaceuticals Files For Chapter 11 Bankruptcy

    09 Oct 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/navidea-biopharmaceuticals-files-for-chapter-11-bankruptcy/

    CONTRACTPHARMA
    09 Oct 2025
    Share Share
    Navidea Extends Reverse Stock Split Authority
    Navidea Extends Reverse Stock Split Authority

    21 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250520421964/en/Navidea-Biopharmaceuticals-Inc.-Announces-Extension-of-Authority-to-Implement-a-Reverse-Stock-Split

    BUSINESSWIRE
    21 May 2025
    Share Share
    Navidea Biopharmaceuticals extends plan to protect tax assets
    Navidea Biopharmaceuticals extends plan to protect tax assets

    31 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250331822538/en/Navidea-Biopharmaceuticals-Announces-the-Extension-of-Plan-Designed-to-Protect-NOLs-and-Other-Tax-Assets

    BUSINESSWIRE
    31 Mar 2025
    Share Share
    Navidea Announces Results of Exploratory Analysis Completed on July 2, 2024
    Navidea Announces Results of Exploratory Analysis Completed on July 2, 2024

    03 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240703199069/en

    BUSINESSWIRE
    03 Jul 2024
    Share Share
    Navidea Biopharmaceuticals Schedules Special Stockholders Meeting For July 8
    Navidea Biopharmaceuticals Schedules Special Stockholders Meeting For July 8

    20 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240620380826/en

    BUSINESSWIRE
    20 Jun 2024
    Share Share
    Navidea Bio Files Form 15 to Voluntarily Suspend its SEC Reporting Obligations
    Navidea Bio Files Form 15 to Voluntarily Suspend its SEC Reporting Obligations

    26 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240126655101/en

    BUSINESSWIRE
    26 Jan 2024
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search